The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Directors and Officers
    • Marketing & Promotions
    • The Antibody Society’s Committees
      • Meetings Committee
      • AIRR Community Working Groups & Sub-Committees
    • Sponsors & Partners
  • Society meetings
    • Computational Antibody Discovery: State of the Art
      • Computational Antibody Discovery Symposium Participants
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2024
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 10 – 12 June, 2025 | Congress Center, Basel Switzerland.
      • Scientific Advisors, Antibody Engineering & Therapeutics Europe
    • FOCIS Symposia
  • AIRR Community
    • AIRR Community News
    • AIRR Community Newsletter
    • AIRR Community Seminar Series
    • AIRR Community Meetings
      • Zooming into the Community III
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • On AIRR – An AIRR Community Podcast
    • AIRR Data Commons
    • AIRR-C Germline Database Resources
    • AIRR Community Publications
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Community Webinar Series
    • AIRR Community Calendar
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2025 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2024 James S. Huston Antibody Science Talent Award Recipient
      • 2023 James S. Huston Antibody Science Talent Award Recipient
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award submission guidelines
    • Research Competitions
      • Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2025 Calendar
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings in 2025
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody News Podcast
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars in 2025
    • The Antibody Series Lectures
    • Antibody Discovery & Development
    • Adaptive Immune Receptor Repertoires
    • Antibodies to Watch
    • Commercializing Antibody Therapeutics
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics

Congratulations to our 2022 Antibody Research Competition winners!

July 26, 2022 by The Antibody Society

The Antibody Society sponsors competitions each year to recognize and encourage the research activities of promising student and postdoctoral fellow members. We are pleased to announce the 2022 Antibody Research Competition winners:

 

 

 

 

Rodrigo García-Valiente (Amsterdam UMC, University of Amsterdam, the Netherlands)
Poster title: Understanding repertoire sequencing data through a multiscale computational model of the germinal center

Dr. Hayden Fisher (University of Southampton, UK)
Poster title: Hinge disulfides in human IgG2 CD40 antibodies modulate activity by regulation of conformation and flexibility

Information on past competitions and winners can be found here.

Filed Under: antibody research, Competition Tagged With: antibody research, competition

Register for our upcoming webinar on BLI and its use in anti-snake venom antibody discovery

July 19, 2022 by Janice Reichert

Biolayer interferometry (BLI) is gaining popularity for protein and small molecule quantitation and kinetics research. The new advancements in biosensors, ease of use, reproducibility and low cost is driving its adoption. Even though BLI is one of the easiest of the tools, as with many other techniques, getting the best data depends on optimization of some key experimental factors. This webinar will discuss the best practices in BLI and result of such implementation by way of an example of screening of a broadly neutralizing antibody of snake venoms.

Snake envenomation results in over 100,000 deaths and 300,000 permanent disabilities in humans annually. Contemporary antivenoms are produced from the polyclonal serum of venom-immunized livestock and are specific to a single or narrow genetic range of related snakes. Could a broadly neutralizing monoclonal antibody, or a cocktail of a few broad components, provide protection from diverse snake venoms? Centi-3FTX-D09, originating from the B-cell memory of a human subject with an extensive history of diverse snake venom exposure, recognized a conserved neutralizing epitope of 3-finger toxins (3FTXs), a dominant snake neurotoxin. Four crystal structures of Centi-3FTX-D09 in complex with 3FTXs from mamba, taipan, krait, and cobra revealed the mechanism of broad neutralization to be epitope mimicry of the interface between these neurotoxins and their native host target, the nicotinic acetylcholine receptor. Centi-3FTX-D09 provided in-vivo protection against diverse 3FTXs and, in combination with the phospholipase inhibitor varespladib, protection against whole venom challenge for diverse, genetically distinct, elapid species.

About the Speakers

Register here!

Filed Under: Antibody discovery Tagged With: antibody discovery, snake venom

Welcome to our new AIRR Community Executive Sub-committee!

July 18, 2022 by Pam Borghardt

We are excited to announce the new AIRR Community Executive Sub-committee recently elected at the AIRR Community Meeting. The AIRR-C Executive Sub-committee comprises a Chair (Victor Greiff), a Chair-Elect (Encarnita Mariotti-Ferrandiz), a Past Chair (Lindsay Cowell), and three elected Members of the AIRR Community (Christian Busse, Nina Luning Prak and Corey Watson). To learn more about the AIRR-C Exec SC members visit their webpages.

Filed Under: AIRR Community Tagged With: Adaptive Immune Receptor Repertoire Community

The Society thanks our retiring Directors

July 15, 2022 by The Antibody Society

The first annual meeting of The Antibody Society’s Board of Directors was held on December 2, 2007. Following their retirement on July 6, 2022, we are recognizing the outstanding contributions of four founding members: Dr. Andrew Bradbury, Prof. Dennis Burton,  Prof. Andreas Plückthun and Prof. Jamie Scott. In addition, we are acknowledging the strong contributions of Dr. Greg Adams who became a Director in 2013 and also retired on July 6th. Dr. Bradbury served as our first, and Prof. Scott as our second President. As stated by Dr. Bradbury: “the Society aimed to provide a forum and voice for the thousands of people working in this area and to help attract and encourage young students to all facets of the field”.  Amongst other things, this initially was done by ensuring the excellent scientific content of the Antibody Engineering & Therapeutics conference. Since that time, the Society has grown into a mature and world-renowned non-profit trade organization with ~ 2400 members from academia, government agencies and industry, and financially supported by over 40 companies ranging from the smallest biotech companies to the largest pharma firms.

The Society thanks Drs Bradbury and Adams and Profs Burton, Plückthun and Scott for their dedication and service, which has enabled the Society to grow and thrive. Each retiring member was given a special award for outstanding contributions to the Society, in the form of a piece of art which was specifically commissioned for them.

More information about The Antibody Society’s Board of Directors can be found here.

Filed Under: The Antibody Society

Announcing the inaugural AIRR Community Service Prize Winner!

July 8, 2022 by Pam Borghardt

We are thrilled to announce the inaugural AIRR Community Service Award winner, which recognizes individuals who have made significant contributions to the AIRR Community. The first recipient of this award was Dr. Christian Busse, a distinguished immunologist and pioneer in the field of AIRR research who was presented with the award at the AIRR Community Meeting VI in La Jolla, California in May 2022. 

The AIRR Community Service Award was established to acknowledge individuals who have demonstrated a deep commitment to the AIRR Community, including contributions to the development of standards and tools for the analysis of immune receptor repertoires, advancing the field through research, and sharing knowledge with other members of the community.

Christian Busse, of DKFZ in Germany, has been an active member of the AIRR Community for many years, serving as a member of the Executive Sub-committee and Co-lead of the Standards Working Group. In these roles he contributes to the development of standards and best practices for AIRR analysis, helping to ensure that the Community continues to advance and grow.

We would like to extend our warmest congratulations to Christian Busse on this well-deserved award. His contributions to the AIRR Community have been truly outstanding, and we are honored to recognize him as the first recipient of the AIRR Community Service Award!

Filed Under: Adaptive immune receptor repertoire, AIRR Community, AIRR Community Service Prize

« Previous Page
Next Page »

mabs

mabs

The Official Journal of The Antibody Society

Career Center

Our Career Center is a premier resource to connect highly qualified talent with matching career opportunities. Visit for details on over 800 jobs!

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

Recent Posts

  • Exciting news – The AIRR Community is turning 10! 🎂 May 8, 2025
  • The Antibody Society (TAbS): Win a FREE Attendance Pass to AET Basel & Present A Poster: Call For Abstracts! March 26, 2025
  • New episode of the On AIRR podcast is here! March 25, 2025

Archives

Follow us online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals